 Value carvedilol congestive heart failure secondary coronary artery disease considerable interest use beta-blocking agents congestive heart failure CHF clinical application limited negative inotropic effects Beta blockers properties advantage Carvedilol beta-blocking agent properties patients chronic CHF secondary heart disease resting ventricular ejection fraction equal diuretics Exercise testing radionuclide ventriculography right-sided cardiac catheterization intraarterial blood pressure weeks carvedilol therapy dosage mg day patients study withdrew Symptomatic hemodynamic improvement patients Heart rate intraarterial blood pressure chronic therapy Mean standard deviation exercise time minutes left ventricular ejection fraction Pulmonary arterial wedge pressure mm Hg mm Hg total systemic vascular resistance Stroke volume index ml ml hemodynamic changes vasodilation myocardial oxygen demand reduction sympathetic overactivity failing heart data carvedilol beneficial effects patients chronic CHF secondary coronary artery disease